Article
Immune Cytolytic Activity Stratifies Molecular Subsets of Human Pancreatic Cancer
23 Dec 2016
Abstract excerpt
Abstract Purpose: Immunotherapy has the potential to improve the dismal prognosis in pancreatic ductal adenocarcinoma (PDA), but clinical trials, including those with single-agent PD-1 or PD-L1 inhibition, have been disappointing. Our aim was to examine the immune landscape of PDA as it relates to aspects of tumor biology, including neoepitope burden. Experimental Design: We used publicly available expression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
